Sterling Capital Management’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
JAIC
Sterling Capital Management's STLN Position: Q3 2026 in Review
Sterling Capital Management increased its Starling Oncology (STLN) stake by 302% in Q3 2026, buying an estimated $10.2K and bringing the position to 2,281 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2351.
Sterling Capital Management first reported a position in STLN in Q2 2025 and has held it in 6 quarters since. 131 funds tracked by Wall St. Rank hold STLN as of Q3 2026.
- Sterling Capital Management held 2,281 shares of Starling Oncology worth $14.4K as of Q3 2026.
- Sterling Capital Management bought 1,714 Starling Oncology shares in Q3 2026, an estimated $10.2K.
- Starling Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2351 holding.
- Sterling Capital Management first reported a position in Starling Oncology in Q2 2025 and has held it in 6 quarters since.
- 131 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.
Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.